Contact Us

Phone 1300 884 450

News

PDS Update

MPA Makes PBAC Submission

MPA made a submission to the PBAC for the consideration of the reimbursement of Nivolumab (Opdivo) and ipilumimab (Yervoy) and...

Sign up for Email Newsletter

Our quarterly e-newsletter includes the latest news, upcoming events and more.
  • This field is for validation purposes and should be left unchanged.